A Study Of The Analgesic (Pain-Relief) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy

Clinical trial NCT01087203 · TERMINATED

Trial details

NCT number: NCT01087203
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Peripheral Neuropathy

Start date: 2010-03-30
Primary completion: 2010-11-18
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.